Mereo BioPharma Group plc (AIM:MPH)

Mereo BioPharma Group Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 16, 2020	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42	49	433	254	73	128
Market Cap Growth	-86.11%	-88.62%	70.57%	249.41%	-43.41%	-27.46%
Enterprise Value	11	13	374	221	14	37
PE Ratio	-	-	-	-	-	10.09
PS Ratio	112.33	132.62	-	32.34	-	3.52
PB Ratio	1.37	1.62	8.89	6.40	1.70	1.46
P/TBV Ratio	1.39	1.64	8.99	6.54	1.70	2.02
EV/Sales Ratio	30.09	36.02	-	28.17	-	1.02
Debt / Equity Ratio	0.01	0.01	0.11	0.12	0.30	0.19
Net Debt / Equity Ratio	-1.00	-1.00	-1.04	-1.02	-1.03	-0.88
Net Debt / EBITDA Ratio	1.08	1.08	1.40	1.94	1.01	3.72
Net Debt / FCF Ratio	1.32	1.32	1.93	2.44	1.08	13.43
Asset Turnover	0.01	0.01	-	0.14	-	0.39
Quick Ratio	9.99	9.99	5.28	6.45	2.89	7.66
Current Ratio	10.47	10.47	5.40	6.72	3.09	7.92
Return on Equity (ROE)	-82.21%	-82.21%	-77.58%	-57.81%	-53.63%	34.85%
Return on Assets (ROA)	-39.41%	-39.41%	-39.99%	-23.57%	-28.67%	-13.82%
Return on Invested Capital (ROIC)	-	-	-	-	-825.95%	-
Return on Capital Employed (ROCE)	-92.70%	-92.70%	-73.10%	-47.60%	-99.40%	-18.40%
Earnings Yield	-74.56%	-63.15%	-7.98%	-9.11%	-48.22%	9.91%
FCF Yield	-55.18%	-46.74%	-6.06%	-6.54%	-55.78%	-4.50%
Buyback Yield / Dilution	-7.77%	-7.77%	-12.16%	-9.33%	-8.63%	-63.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.